Abstract
Introduction
Active sacroiliitis represents the hallmark of axial spondyloarthritis (axSpA) and manifests as inflammatory low back pain associated with morning stiffness (MS). Sometimes, the combination of non-steroidal anti-inflammatory drugs (NSAIDs) and biological disease modifying drugs (bDMARDs) proves unsatisfactory in achieving a remission.
Materials and methods
We enrolled patients affected with active sacroiliitis confirmed via magnetic resonance imaging (MRI) and treated with a corticosteroid sacroiliac joint injection (SIJI) via ultrasound guidance.
After SIJI, we evaluated visual–analogue scale (VAS) and MS pain changes. As controls, we selected axSpA patients starting bDMARDs.
Results
We enrolled 26 patients (mean age 55 ± 14 years; 25 females and 1 male; > 95% treated with NSAIDs; 46% on bDMARDs; 75.82 ± 123 months) and examined a total of 47 treated joints. We detected a 48% reduction in VAS pain after 24 h. Moreover, we observed a significant reduction (p < 0.0001) of VAS pain between the baseline and every subsequent follow-up visit. Further, a significant difference in VAS pain compared to the baseline in the controls was observed starting from week 12. There was a significant reduction in MS after 1 week due to SIJIs, while in the controls the first significant change from the baseline in MS was detected after 12 weeks. The efficacy of infiltrative therapy lasted up to 6 months: persistent VAS as well as MS pain reduction was observed.
Conclusions
US-guided SIJI represents an effective and safe technique for patients who have active sacroiliitis yet are ineligible for biologic treatment or who experience unsatisfactory disease control despite receiving therapy.
Similar content being viewed by others
References
Rudwaleit M, Van Der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. https://doi.org/10.1136/ard.2009.108233
Rudwaleit M, Van Der Heijde D, Landewé R et al (2011) The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31. https://doi.org/10.1136/ard.2010.133645
Cantini F, Nannini C, Niccoli L et al (2015) Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 14:503–509. https://doi.org/10.1016/j.autrev.2015.01.011
Fouad AZ, Ayad AE, Tawfik KAW et al (2021) The Success Rate of Ultrasound-Guided Sacroiliac Joint Steroid Injections in Sacroiliitis: Are We Getting Better? Pain Pract 21:404–410. https://doi.org/10.1111/papr.12967
Althoff CE, Bollow M, Feist E et al (2015) CT-guided corticosteroid injection of the sacroiliac joints: quality assurance and standardized prospective evaluation of long-term effectiveness over six months. Clin Rheumatol 34:1079–1084. https://doi.org/10.1007/s10067-015-2937-7
Fritz J, Henes JC, Thomas C et al (2008) Diagnostic and interventional MRI of the sacroiliac joints using a 1.5-T open-bore magnet: a one-stop-shopping approach. Am J Roentgenol 191:1717–1724. https://doi.org/10.2214/AJR.08.1075
Wendling D (2020) Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence? Jt Bone Spine 87:209–213
Pekkafali MZ, Kiralp MZ, Başekim CÇ et al (2003) Sacroiliac joint injections performed with sonographic guidance. J Ultrasound Med 22:553–559. https://doi.org/10.7863/jum.2003.22.6.553
Harirforoosh S, Asghar W, F Jamali (2014) Adverse effects of nonsteroidal antiinflammatory drugs. J Pharm Pharm Sci (www.cspsCanada.org) 16(5):821–847
Ramírez Huaranga MA, Castro Corredor D, Plasencia Ezaine AE et al (2022) First Spanish study on the effectiveness of ultrasound-guided sacroiliac joint injection in patients with spondyloarthritis. Rheumatol Adv Pract. https://doi.org/10.1093/rap/rkac036
Kokar S, Kayhan Ö, Şencan S, Gündüz OH (2021) The role of sacroiliac joint steroid injections in the treatment of axial spondyloarthritis. Arch Rheumatol 36:80–88. https://doi.org/10.46497/ArchRheumatol.2021.8043
Günaydin I, Pereira PL, Fritz J et al (2006) Magnetic resonance imaging guided corticosteroid injection of sacroiliac joints in patients with spondylarthropathy. Are multiple injections more beneficial? Rheumatol Int 26:396–400. https://doi.org/10.1007/s00296-005-0008-0
Pereira PL, Günaydin I, Trübenbach J, Dammann F, Remy CT, Kötter I, Schick F, Koenig CW, Claussen CD (2000) Interventional MR imaging for injection of sacroiliac joints in patients with sacroiliitis. AJR Am J Roentgenol 175(1):265–266. https://doi.org/10.2214/ajr.175.1.1750265
Van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770 (Epub 2017 Jan 13)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors deny any conflict of interest.
Funding
The authors deny any funding.
Ethical Statements
The present study was approved by a local ethical committee (protocol number 22271) and conducted in accordance with the Declaration of Helsinki and its late amendments.
Informed consent
The infiltrative technique was explained to the patient and a written informed consent was obtained.
Consent to publish
Each patient provided written informed consent to be enrolled.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Al Khayyat, S.G., Fogliame, G., Barbagli, S. et al. Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience. J Ultrasound 26, 479–486 (2023). https://doi.org/10.1007/s40477-022-00736-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40477-022-00736-6